Brief: MaxCyte Says Phase I Clinical Trial Of MCY-M11 Progressed

MaxCyte

08/05/2019 07:43

May 8 (Reuters) - MaxCyte Inc  MXCT.L :
    * PHASE I CLINICAL TRIAL OF MCY-M11 PROGRESSED
    * MAXCYTE PROGRESSES PHASE I CLINICAL TRIAL OF LEAD
MRNA-BASED
CELL THERAPY FROM ITS CARMA PLATFORM
    * NO DOSE-LIMITING TOXICITIES OR SAFETY CONCERNS OBSERVED IN
FIRST
COHORT OF TREATED PATIENTS
    * FEASIBILITY OF STREAMLINED, FASTER CAR THERAPY
MANUFACTURING
PROCESS CONFIRMED
    * DOSING INITIATED IN SECOND COHORT OF PATIENTS

Source text for Eikon:  ID:nRSH2936Ya 
Further company coverage:  MXCT.L 

 ((Reuters.Briefs@thomsonreuters.com;))